Table 2. Distribution (N and %) of stage at diagnosis and vital status/cause of death by histological type and subtype.
Florida 2005–2016.
| All-Combined | Type 1 EC | Type 2 EC | ||||||
|---|---|---|---|---|---|---|---|---|
| Low-Grade Endometrioid | High-Grade Endometrioid | Clear Cell | Mixed High-Grade | Carcino-sarcoma | Serous | Total | ||
| Total Cases | 27,089 | 16,619 | 5,954 | 425 | 1,372 | 1,082 | 1,637 | 10,470 |
| Stage | ||||||||
| Localized | 18,214 | 13,158 | 3,214 | 204 | 572 | 473 | 593 | 5,056 |
| 66.4% | 78.2% | 53.4% | 47.7% | 52.5% | 33.9% | 35.9% | 47.8% | |
| Regional | 6,253 | 2,928 | 1,675 | 151 | 380 | 501 | 618 | 3325 |
| 22.8% | 17.4% | 27.8% | 35.3% | 34.9% | 35.9% | 37.4% | 31.4% | |
| Distant | 1,905 | 304 | 715 | 54 | 114 | 338 | 380 | 1,601 |
| 6.9% | 1.8% | 11.9% | 12.6% | 10.5% | 24.2% | 23.0% | 15.1% | |
| Unknown | 1047 | 445 | 415 | 19 | 24 | 84 | 60 | 602 |
| 3.8% | 2.6% | 6.9% | 4.4% | 2.2% | 6.0% | 3.6% | 5.7% | |
| Vital status | ||||||||
| Dead | 6,069 | 2,247 | 1,881 | 155 | 783 | 299 | 704 | 3,822 |
| 22.4% | 13.5% | 31.6% | 36.5% | 57.1% | 27.6% | 43.0% | 36.5% | |
| From EC | 4,100 | 1,043 | 1,412 | 121 | 235 | 692 | 597 | 3,057 |
| 15.1% | 6.3% | 23.7% | 28.5% | 21.7% | 50.4% | 36.5% | 29.2% | |
| Other Causes | 1,969 | 1,204 | 469 | 34 | 64 | 91 | 107 | 765 |
| 7.3% | 7.2% | 7.9% | 8.0% | 5.9% | 6.6% | 6.5% | 7.3% | |
| Alive | 21,020 | 14,372 | 4,073 | 270 | 589 | 783 | 933 | 6,648 |
| 77.6% | 86.5% | 68.4% | 63.5% | 42.9% | 72.4% | 57.0% | 63.5% | |